Navigation Links
Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025
Date:5/4/2010

of Maxalt (Rizatriptan)

7.4 Zomig's Decline in Sales

7.4.1 Development of Zomig (Zolmitriptan)

7.5 Relpax Will Exhibit Loss of Revenue from 2010-2025

7.5.1 Development of Relpax (Eletriptan)

7.6 Other Agents

7.7 What Does the Future Hold for Migraine Therapy?

7.8 Unmet Needs in the Treatment of Migraine

8. Neuropathic Pain and Local Anaesthetics Markets 2010-2025

8.1 Introduction

8.1.1 Anti-Epileptic Drugs Market

8.2 Anti-Epileptic Market Analysis and Forecast

8.2.1 Lyrica

8.2.2 The Development of Lyrica (Pregabalin)

8.2.3 Topamax (Topiramate): Impending Patent Expiry

8.2.4 Topamax: Challenges this Product has to Face

8.2.5 Other Agents

8.3 Local Anaesthetic Market Analysis and Forecast

8.3.1 Lidoderm (Lidocaine) Forecast

8.3.2 Lidoderm: Market Leader for the Local Anaesthetic Market

8.3.3 Other Agents

9. SWOT Analysis of the Global Pain Drug Market

9.1 SWOT Analysis

9.2 Market Drivers

9.3 Market Restraints

9.4 The Pain Market Suffered After the Withdrawal of COX-2 Inhibitors

9.5 Lack of Adequate Reimbursement Limits Potential of Pain Drugs

9.6 Patients Dependent on Reformulations of Existing Drugs


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Reportlinker Adds The Outlook for Pharmaceuticals in Western Europe
2. Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016
3. Reportlinker Adds U.S. Market for Hearing Aids and Audiology Devices 2010 (Includes Audiologist Survey)
4. Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016
5. Reportlinker Adds World Wound Management Products
6. Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016
7. Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]
8. Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015
9. Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015
10. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
11. Reportlinker Adds Top Ten Worlds Leading Orthopedics Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... TORONTO , May 22, 2013 /PRNewswire/ ... announced three presentations demonstrating the superiority of the AE37 ... Antigen Express, Inc. ( www.antigenexpress.com ). The presentations will ... Society of Clinical Oncology (ASCO) to be held in ... June 4, 2013. The presentation entitled " ...
(Date:5/22/2013)... -- Ranbaxy Laboratories Limited (hereafter, Ranbaxy), a subsidiary ... announced on May 22 the actions that Ranbaxy ... conduct under prior management ( ... to support Ranbaxy in its efforts to address ... led to the investigations by the U.S. Department ...
(Date:5/22/2013)... 22. Mai 2013  Grifols, ein globales ... Barcelona , Spanien, präsentierte die ... höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den ... (AAT) auf ein Niveau anhebt, das innerhalb ... liegt. ATT-Mangel ist eine lebensbedrohliche, genetische Erkrankung, ...
Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4
(Date:5/22/2013)... 22, 2013 Cedars-Sinai Heart Institute is honoring ... pioneer in modern mitral heart valve repair, Alain ... Corday, MD, International Prize in Heart Research. The ... recognize physicians and scientists conducting groundbreaking research, or ... medicine. , Carpentier is a leading ...
(Date:5/22/2013)... A new study provides neurobiological evidence for ... in people with insomnia, which may have implications ... , "Insomnia has been consistently identified as a ... Franzen, PhD, an assistant professor of psychiatry at ... in the brain circuitry underlying emotion regulation may ...
(Date:5/22/2013)... May 22, 2013 Digital Advertising Agency, ... behalf of its social media management client, Primal ... year's supply of the all-natural organic deodorant. The contest ... of the rapidly-growing start-up deodorant company based in Tampa, ... contest or sweepstakes on a Facebook page is a ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 DiscountFurnaceFilter.com ... quality merchandise ranging from furnace filters, dehumidifiers, fans, ... is excited to add Stadler Form's product line ... summer product line (fans, aroma diffusers and dehumidifiers) ... Form’s Otto Fan is the perfect combination of ...
(Date:5/22/2013)... York, NY and Troy, NY (PRWEB) May 22, ... Medicine at Mount Sinai and Rensselaer Polytechnic Institute ... educational programs, research, and development of new diagnostic ... alliance was commemorated in a signing ceremony on ... initiative to use their expertise—Rensselaer’s in engineering and ...
Breaking Medicine News(10 mins):Health News:Heart valve repair innovator receives Cedars-Sinai Heart Institute's Corday Prize in Heart Research 2Health News:Study shows that insomnia may cause dysfunction in emotional brain circuitry 2Health News:Social Media Management Firm, 21Digital, Launches National Facebook Sweepstakes for Client, Primal Pit Paste 2Health News:DiscountFurnaceFilter.com Now Offers Stadler Form Products - Providing Solutions to All Your Summer Needs 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 3Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 4Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 5Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 6Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 7
... Oct. 24 CME LLC (http://www.CMELLC.com ), ... programs,since 1978, today announced it has been granted ... as an approved sponsor of,continuing medical education for ... full approval as part of the APA,s,Continuing Education ...
... developed a new type of biodegradable nanoparticle. The ... makes it easier to target tumour tissue. These ... release of anticancer drugs. Rijcken recently gained her ... , Anticancer drugs sometimes have very harmful side ...
... used to be dogma that the brain was shut away ... outside forces of nature. But thats not how it is ... of Kevin Tracey, MD, it turns out that the brain ... the bodys inflammatory response to infection and autoimmune diseases. Understanding ...
... University of Liverpool have found that 73% of avian ... the initial infected farm, but larger outbreaks are more ... team from the Universitys Faculty of Veterinary Science and ... of Environment, Food and Rural Affairs (DEFRA) to produce ...
... Disease, ROCKVILLE, Md., Oct. 24 EntreMed, ... developing,therapeutics for the treatment of cancer and inflammatory ... Phase 2, open-label study for,Panzem(R) NCD (2ME2 or ... presented by Dr. Daniela Matei, principal investigator for,the ...
... Calif., Oct. 24 Anesiva,Inc. (Nasdaq: ANSV ) ... the markets close on Thursday, November 1, 2007 and ... day. Members of Anesiva,s,management team will discuss financial results ... overview of the company,s product pipeline, recent,events and milestones. ...
Cached Medicine News:Health News:CME LLC Granted Five-Year Full Approval by the American Psychological Association 2Health News:Nanoballs deliver drugs 2Health News:Scientists discover a direct route from the brain to the immune system 2Health News:Large avian flu outbreaks more likely to involve duck meat industry, experts find 2Health News:EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study 2Health News:EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study 3Health News:EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study 4Health News:Anesiva to Announce Third Quarter 2007 Financial Results and Host Webcast Conference Call on November 1, 2007 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: